Skip to main content
Livermore
Livermore
ZHEN

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Nov 20, 2025

Accession no.
0001193125-25-290115
Filed
Nov 20, 2025, 6:10 PM ET
Trade date
Nov 20, 2025
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 7 non-derivative transactions. Open-market purchases total $771.3K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 20, 2025Common StockPPurchaseAcquired+119,129$1.32+$157,250.28215,665,577Indirect
Nov 20, 2025Common StockPPurchaseAcquired+47,105$1.33+$62,414.13215,712,682Indirect
Nov 20, 2025Common StockPPurchaseAcquired+211,948$1.33+$281,890.84215,924,630Indirect
Nov 20, 2025Common StockPPurchaseAcquired+161,818$1.34+$216,027.03216,086,448Indirect
Nov 20, 2025Common StockPPurchaseAcquired+24,579$1.34+$32,935.86216,111,027Indirect
Nov 20, 2025Common StockPPurchaseAcquired+1,757$1.35+$2,363.17216,112,784Indirect
Nov 20, 2025Common StockPPurchaseAcquired+13,664$1.35+$18,446.4216,126,448Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)